A 3-month course of romosozumab followed by denosumab produced bone density gains comparable to those of the standard 12-month regimen in postmenopausal women at high fracture risk.

Entera said that the FDA backed its plan for a single large late-stage clinical trial of its experimental once-daily pill, ...

Researchers found that women taking menopausal hormone therapy had a 69% lower risk of low bone mineral density than those ...

Researchers found a bone switch that could stop osteoporosis before a fracture happens. Here are the biggest questions answered.

Lumbar spine bone mineral density improved significantly and was maintained during long-term tumor necrosis factor inhibitor (TNFi) treatment for axial spondyloarthritis. Axial spondyloarthritis, a ...

Patients with prostate cancer receiving ADT who are vitamin D deficient may receive the most bone density benefits from high-dose vitamin D. Vitamin D supplements demonstrated significant benefits in ...

Osteoporosis occurs when the body fails to replace old bone as it is broken down. This causes bones to become brittle and ...

Osteoporosis weakens bones by reducing density, but bisphosphonates can help preserve strength by slowing down bone loss. Bisphosphonates are drugs made from synthetic compounds that resemble natural ...

A new review published in Calcified Tissue International highlights major advances in understanding and preventing bone loss ...

Medicare coverage of a new osteoporosis screening tool may help to address the challenge of identifying and treating patients ...